Pages
(Move to ...)
Home
▼
Showing posts with label
Mead Johnson
.
Show all posts
Showing posts with label
Mead Johnson
.
Show all posts
Tuesday, December 22, 2009
2009 Exits/Financings DOTY Nominee: BMS Spins Off Mead Johnson
›
It's time for the IN VIVO Blog's Second Annual Deal of the Year! competition. This year we're presenting awards in three categor...
Tuesday, November 17, 2009
Bristol Says Buh-Bye to Formula for Stability, Hello to Buyback
›
It's no secret that Bristol-Myers Squibb has spent the last couple years solidifying its stance as a pure biopharma play. We've docu...
Wednesday, February 11, 2009
Investors Dig Baby Formula, Not Yet Ready for Solid Foods
›
Against the odds and a miserable market Bristol-Myers Squibb milked investors for $720 million yesterday. According to Reuters , BMS sold 3...
Monday, December 15, 2008
Deals of the Year Nominee: Novartis/Alcon
›
Ah, awards season. Why should film critics have all the fun? And voting! It's not just for presidential elections. This year your IN VIV...
2 comments:
›
Home
View web version
